| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.8M | +32.7% |
| Cost of Revenue | $7.2M | +31.7% |
| Gross Profit | $11.6M | +33.3% |
| R&D Expense | $1.3M | +47.8% |
| SG&A Expense | $9.0M | +17.2% |
| Operating Income | $1.1M | — |
| Pre-tax Income | $1.2M | +1255.1% |
| Income Tax | $12K | -20.0% |
| Net Income | $1.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | +43.6% |
| Accounts Receivable | $2.4M | +35.5% |
| Inventory | $3.2M | +23.6% |
| Current Assets | $11.2M | +35.2% |
| Total Assets | $13.6M | +21.7% |
| Current Liabilities | $2.8M | +77.1% |
| Total Liabilities | $3.4M | +31.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.6M | +434.3% |
| Capital Expenditures | $55K | +0.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | -$5K | +0.0% |
| Free Cash Flow | $1.6M | +390.7% |
| +1513.5% |
| EPS (Basic) | $0.11 | +1000.0% |
| EPS (Diluted) | $0.11 | +1000.0% |
| Stockholders' Equity |
| $10.2M |
| +18.8% |